24 Immunohistochemical Validation of B7-H4 (DD-O110) asa Biomarker of Ovarian Cancer: Correlation with CA-125

Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas

Volumn 4, Issue , 2006, Pages 499-503

  Miyatake, Takashi ^a   Shroyer, Kenneth R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649373090     PISSN: 18745784     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5784(05)80110-2     Document Type: Chapter

References (13)

1. American C.S. American Cancer Society Facts and Figures 2003 (2003), American Cancer Society, Washington, DC 1-52
2. Carreno B.M., and Collins M. BTLA: a new inhibitory receptor with a B7-like ligand. Trends. Immunol. 24 (2003) 524-527
3. Choi I.H., Zhu G., Sica G.L., Strome S.E., Cheville J.C., Lau J.S., Zhu Y., Flies D.B., Tamada K., and Chen L. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J. Immunol. 171 (2003) 4650-4654
4. Jacobs I., and Bast R.C.(jrJr.). The CA-125 tumour-associated antigen: a review of the literature. Hum. Reprod. 4 (1989) 1-12
5. Jacobs I.J., Skates S.J., MacDonald N., Menon U., Rosenthal A.N., Davies A.R., Woolas R., Jeyarajah A.R., Sibley K., Lowe D.G., and Oram D.H. Screening for ovarian cancer: a pilot randomised control trial. Lancet 353 (1999) 1207-1210
6. Kui Wong N., Easton R.L., Panico M., Sutton-Smith M., Morrison J.C., Lattanzio F.A., Morris H.R., Clark G.F., Dell A., and atankar M.S. Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125. J. Biol. Chem. 275 (2003) 28619-28634
7. Lagendijk J.H., Mullink H., van Diest P.J., Meijer G.A., and Meijer C.J. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin: comparison between a sta. J. Clin. Pathol. 52 (1999) 283-290
8. Lloyd K.O., Yin B.W., and Kudryashov V. Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule. Int. J. Cancer. 71 (1997) 842-850
9. Multhaupt H.A., Arenas-Elliott C.P., and Warhol M.J. Comparison of glycoprotein expression between ovarian and colon adenocarcinomas. Arch. Pathol. Lab. Med. 123 (1999) 909-916
10. Prasad D.V., Richards S., Mai X.M., and Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 15 (2003) 863-873
11. Sica G.L., Choi I.H., Zhu G., Tamada K., Wang S.D., Tamura H., Chapoval A.I., Flies D.B., Bajorath J., and Chen L. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18 (2003) 849-861
12. Sjovall K., Nilsson B., and Einhorn N. The significance of serum CA 125 elevation in malignant and nonmalignant diseases. Gynecol. Oncol. 85 (2002) 175-178
13. Tringler B., Zhou S., Pilkington G., Torkko K.C., Singh M., Lucia M.S., Heinz D.E., Papkoff J., and Shroyer K.R. B7-H4 is highly expressed in ductal and lobular breast cancer. Clin. Cancer Res. 11 (2005) 1842-1848